TDX THYROXINE— 510(k) K830683

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K830683 for TDX THYROXINE, Substantially Equivalent on 1983-04-06. Applicant: Abbott Laboratories. Device class: 2.

Clearance details

Applicant: Abbott Laboratories
Product code: Code KLI
Device class: Class 2
Regulation: 21 CFR 862.1700
Advisory panel: Clinical Chemistry
Date received: 1983-03-04
Decision date: 1983-04-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KLI

K160495 — VITROS® Automation Solutions2016-10-18
K131515 — ACE -GT REAGENT; ACE LIPASE RAGENT; ACE T4 REAGENT2013-08-14
K103484 — GSP NEONATAL THYROXINE (T4)2011-04-22
K082638 — ADVIA CENTAUR SYSTEM WITH STREAMLAB ANALYTICAL WORKCELL2009-02-26
K030860 — ACCUBIND NEONATAL T4 MICROPLATE EIA, MODEL 2625-3002003-08-22

More clearances from Abbott Laboratories

K252424 — Anti-HCV Next2026-04-28
K243500 — ARCHITECT iGentamicin2025-07-09
K243168 — Alinity i Rubella IgG2025-06-20
K243283 — Alinity h-series System2025-02-20
K233932 — Alinity i Toxo IgM2024-08-30

Data sourced from openFDA. This site is unofficial and independent of the FDA.